FDA Approves GE’s Veo Low-Dose CT Technology

The FDA has cleared GE Healthcare’s Veo computed tomography technology, which delivers clearer images at lower doses, according to a GE Healthcare news release.

Advertisement

 

Veo is the first FDA-approved CT system using the model-based iterative reconstruction technique, which is already available on GE Discovery CT750 HD systems in Europe, Canada and parts of Asia.

 

Current Veo users in Europe report successful chest CTs done with an equivalent amount of medical radiation dose as a chest x-ray, or less than one-tenth of one mSv.

 

Related Articles on Computed Tomography Systems:

GE Healthcare Launches Compact CT System After FDA Clearance

Report: CT Scanner Use Rising 6% Per Year

Study: Computed Tomography Volumetry Accurately Assesses Endocrine Function in Pancreas


 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.